Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 12/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.37 |
| ▸ | XDH | P47989 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7046398 | 0.92 | XDH (0.38) | CTSSCYP3A4CYP2C9FAAHCES1 | |
| SCHEMBL6464414 | 0.88 | FAAH (0.38) | CTSSCYP3A4CYP2C9FAAHCES1 | |
| SCHEMBL7187232 | 0.87 | CTSS (0.38) | CTSSCYP3A4CYP2C9 | |
| SCHEMBL6468442 | 0.81 | DAGLA (0.55) | FAAHCES1DAGLAXDH | |
| SCHEMBL7044356 | 0.81 | CTSS (0.37) | CTSSCYP3A4CYP2C9FAAHCES1 | |
| SCHEMBL7049525 | 0.79 | GART (0.38) | CTSSCYP3A4CYP2C9FAAHCES1 | |
| SCHEMBL6468432 | 0.78 | GART (0.34) | CTSSCYP3A4CYP2C9NPC1RAB9A | |
| SCHEMBL7045925 | 0.77 | CTSS (0.36) | CTSSCYP3A4CYP2C9NPC1 | |
| SCHEMBL7114802 | 0.76 | LMNA (0.38) | CTSS | |
| SCHEMBL7045927 | 0.76 | CTSS (0.38) | CTSSCYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1516877-A1 | Amine derivatives as protease inhibitors | AXYS PHARMACEUTICALS, INC. (US) | 2005-03-23 | — | — | EP | disclosed |